Copy of Newspaper Publication

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 SUN Website: www.sunpharma.com Email: secretarial@sunpharma.com PHARMA CIN: L24230GJ1993PLC019050 31 October 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Newspaper Advertisements This is to inform that the Company has published newspaper advertisements [All editions of Financial Express (in English) and Ahmedabad Edition of Financial Express (in Gujarati)] on 31 October 2026, containing information about the Unaudited Financial Results for the quarter and half year ended 30 September 2026. Copies of newspaper clippings are attached as Annexure-A, which is also available on the Company’s website at www.sunpharma.com. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives Annexure-A AXITA COTTON LIMITED ��������� ������� .., r• con oN CIN: L01632GJ201:lPLC076059 Rcglstered Office: Survey t,10. 324 357 358, Kadi, Thal Road, Borisana, Kadi, Mahcsana • 38271 S, Gujarat, Bharat. Corporate Office: Rannade House, First Floor, Opp. Sankalp Grace 3, Near lshan Bunglows, Shilaj, Ahmedabad • 380059, II II Gujarat, Bharat. Telephone: +91·6358747514 £mail: cs@axitacotton.com Website: wv.~v.axitacotton.com ������������������� STATEMENT OF UNAUDITED (STANDALONE) FINANCIAL RESULTS ������ FOR THE QUARTER AND HALF YEAR ENDED ON SEPTEMBER 30, 2026 The Board of Directors of the Company at their meeting held on Thursday, October 29, 2026, approved the Unaudited (Standalone) Financial Results of the Company, for the these financials results pursuant to regulations 33 of SEBI {listing Obligation and Disclosure requirements.) Regulation, 2015 as amended. The full format of Unaudited {Standalone) financial Results is available on the BSE Limited website at www.bseindia.oom, National Stock Exchange Limited website at https://axitacotton.com/storage/ 2020/06/3rd-BM-FR-Outcome-29102026.pdf and the same can also beaccessed by scanning following Quick Response (QR) Code. Sd/· Place: Kadi, Mahesana Chairman cum Managing Director Date: October 29, 2026 DIN: 0662664-6 Note: The above Intimation is in accordance with Regulation 33 read with Regulation 47(1) of the SEBI (Listing Syrma SGS Technology Limited CIN:L30007MH2004PLCf"4a16S- Regd. Office: Und f601, Flo1al Oed( Plata, Andheri East Mumbai-400093. ���������������� Tel+ 9122 4036 3000. Website: www.syrmasgs.oom. E•m.ail 10: fwestor.relaiioos@syrrnasgs.oom Standalone COflSOlidated Sr. C:unent Cuirent Six Corresponding Year Current Currtnl Six Corresponding Year Particulars 3<l September 30 September 30 S.ptombor 31M atch 30 September 30 Soptember 311 Sepiomb<r 31 M•rch 2026 2026 2025 2026 2026 2026 2025 2026 1 Total Income from Operations 18,151.28 32,706,33 10;967.9() 44,079.22 19,995.48 36,032.30 11,546 31 48.568.66 2 Net Profit for !he period befo,e tax 1,424.32 2.684.40 681.38 3.719.84 1,652.10 3.060.30 895.00 4,453.76 and Other Compwheosillo klcome (aft« mx)) t,073,90 2,005.22 656.20 2,941.88 1,237.67 2,287.39 681.63 3.520.71 5 EQlity Share Cspit..1! 1,926.09 1.926.09 1.923.tO 1,926.25 1.926.09 1.926.09 1.923.09 1.926.25 Ba4anoo SM:aL of Ct.fl'l'e(lt Y\1a, NA 29.460.71 NA 27,689.36 NA 28,489.63 NA 26,695.63 ����������� (11Basic(Rs.1 5.62 t0.50 3.51 15.64 6.08 11.27 3.44 16.94 Note: Ocsclosure Requirements) Re91.Qtions, 2015. The~ rormat of lheS taiidalone and Consolida\ed Financial Re,stl!s are availahle on lhe webs~esof 8SE (wNW.bseindia.com), NSE jwww.nseincla.com)andCompany(hllps:/lsy,masg,.com/). Sell· Place: Gurugram Managing Difecto, Dato: SO October 2&26 DIN : 00198825 Sun Pharmaceutical Industries Limited Regd. Office: SPARC, Tandalja, Vadodara - 390 012, Gujarat, India Corpora1e Office: Sun House, Plot No. 201 B/1, Western Express Highway, PHARMA Tel: 022-43244324 ) CIN: L24230GJ1993PLC019050 www.sunpharma.com secretarial@sunnharma.com Website: Email: Unaudited Financial Results for the quarter and half year ended 30 September 2026 ������������ The Unaudited Financial Results of Sun Pharmaceutical Industries limited ("Sun Pharma")forthe quarter and half year ended 30 September (QR) code to access lhe 2026 {"Q2 FY27 Results") have been filed with the $tock Exchanges as per Q2 FY27 Results. Regulation 33 of the SEBI (Listing Obligations and Disclosure RP·SanfivGoenka r~r Requirements) Regulations, 2015. Group G,owlr.g t.~cc;~s. Q2 FY27 Result s are available on Sun Pharma website DIGldrive Digidrive Distributors Limited www.sunpharma.com, and also on the websites of the Stock Exchanges, i.e., www.bseindia.com and www.nseindia.com CIN: L51909WB2022PLC252287 Registered .Office: 33, Jessore Road, Oum Oum, Koikata - 700 028 For and on behalf of the Board Website: www.digidrivelimited.com. Email id: digidrlve.sec@rpsg.in Kirti Ganorkar EXTRACT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE Managing Director 2ND QUARTER AND HALF YEAR ENDED 30 SEPTEMBER, 2026 Mumbai, 30 October 2026 (Rs. in Lakhs except as otherwise stated) Consolidated PARTICULARS ended ended ended oodod ~PGIM (before tax and exceptional items) 856 120 892 117 828 3 Net ProfiV(Loss) for the period before tax Notes: Otrarter Quarter Half Year Haff Year Year PARTICULARS No. 30-Sep-2026 30-5,p,2025 30-Sep-2026 30-Sep-2025 31-Mar-2026 ������������ (Unaudited) (Unaudited) (Unaudited) (Unaudited) jAud~ed) 1 Total Income from Operations (inctuding other income) 1750 836 2319 1370 3762 2 Net ProfiV(Loss) for the period (before tax and exceptional Items) 896 5 869 2 891 3 Net ProfiV(Loss) for the period before tax (after exceptional Items) 896 5 869 2 887 4 Net ProfiV(Loss) for the period after tax (after exceptional items) 690 60 654 so 664 5 Total Comprehensive Income for the period (4022) (1540) (929) 1040 (164) 6 Paid-up Equity Share Capital (Face Value ol Rs.10/-each) 3856 3856 3856 3856 3856 7 Other Equity 23087 2. The above is an extract-of the detailed format of Unaudited Standalone and Consolidated Financial Results for the 2nd quarter ������������������������������������� and haff year ended on 30 September, 2026 filed with Stoel< Exchanges under Regulation 33 of the SEBI (Listing and other ������������������������������������ Disclosure Requirements} Regulations, 2015. The full fonnat of. Unaudited Standalone and Consolidated Financial Resu11s are available on stock exchange websites (www.nselndla.com and www.bsefndla.com) and on the Company's website 3 The above Unaudited Standalone and Consolidated Financial Results for the 2nd quarter and half year ended 30 September, ����������������������������������������� 2026 have been ,eviewed and recommended by the Audit Committe.e in its meeting held on 30 October, 2026 and approved ����������������������������������������� by the Board of Directors of the Company at its meeting held on even date. These results have been subjected to "limited review• by the Statutory Auditors or the Company who have Issued an unmodified review report on the Unaudited StandalOne and Consolidated Financial Results for the 2nd quarter and half year ended 30 September, 2026. The same cao be accessed by scanning the QR oode provided below. On behalf of the Board Kiran Bandekar Place : Kolkala Managing Director Date .: 30. Oc tober, 2026 .. DIN: 10245133 epaper.financialexpress.com AXITA COTTON LIMITED AXJtAcorro• CIN:L01632G)2013PLC076059 Registered Office: Sun•ey No. 324 357 358, Kadi. Thol Road, Borisana, Kadi. Mahesana • 382715, Gujarat, Bharat. Corporate Office: Ranuade House, First Floor. Opp. Sankalp Grace 3, Near lshan Bunglows, Shilaj,Ahmedabad -380059, Gujarat, Bharat. Telephone: +91-6358747514 II Email: cs@a [Showing first 8,000 characters — download PDF for full document]